FIELD: medicine; pharmaceuticals.
SUBSTANCE: group of inventions relates to the field of medicine and pharmaceuticals. First invention is a pharmaceutical composition for treating addiction, containing a first pharmaceutically active agent, which is metyrapol or a pharmaceutically acceptable salt thereof, and a second pharmaceutically active agent, which is benzodiazepine, prepared for oral or topical administration to a patient, where both metyrapol and benzodiazepine are present in the composition in an amount which is not effective for treating said disease when administered separately, additionally comprising a third pharmaceutically active agent which temporarily affects the blood-brain barrier, which is mannitol or bradykinin. Second invention is a method for treating a patient suffering from addiction, including identifying a patient in need of treatment and administering said composition to the patient.
EFFECT: compositions and methods for treating addiction, mental disorders and neurodegenerative disease are disclosed.
5 cl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINATION OF SOMATOSTATIN ANALOGUES WITH 11β-HYDROXYLASE INHIBITORS | 2013 |
|
RU2663455C2 |
| CFR RECEPTOR ANTAGONISTS FOR TREATMENT OF CONGENITAL ADRENAL HYPERPLASIA | 2015 |
|
RU2812318C2 |
| CFR RECEPTOR ANTAGONISTS FOR TREATING CONGENITAL ADRENAL HYPERPLASIA | 2015 |
|
RU2718918C2 |
| ADRENOCORTICOTROPIC HORMONE ANALOGUES AND RELATED METHODS | 2005 |
|
RU2407751C2 |
| APPLICATION OF (11BETA, 17BETA)-11-(1,3-BENZODIOXOL-5-IL)-17-HYDROXY-17-(1-PROPYNYL)ESTRA-4,9-DIEN-3-ON AT TREATING SIGNIFICANT DEPRESSIVE DISORDER | 2002 |
|
RU2302245C2 |
| USE OF MAVOGLURANT TO REDUCE COCAINE INTAKE OR TO PREVENT RECURRENT COCAINE INTAKE | 2018 |
|
RU2804834C2 |
| USE OF MAVOGLURANT TO REDUCE ALCOHOL USE OR TO PREVENT RECURRENT ALCOHOL USE | 2018 |
|
RU2806869C2 |
| HYDROCORTISONE COMPOSITION WITH CONTROLLED RELEASE | 2013 |
|
RU2619869C2 |
| METHOD OF DETERMINING INDICATIONS FOR PHOTODYNAMIC THERAPY OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY | 2012 |
|
RU2495620C1 |
| METHOD OF TREATING HYPERCORTISOLEMIA, HEADACHES, NEUROPATHIC PAIN AND RELATED DISORDERS | 2011 |
|
RU2561588C2 |
